Literature DB >> 16369749

Partial resection of the second portion of the duodenum for gastrointestinal stromal tumor after effective transarterial embolization.

Naoto Kurihara1, Kiyoshi Kikuchi, Minoru Tanabe, Yusuke Kumamoto, Akira Tsuyuki, Yasuo Fujishiro, Yoshihide Otani, Tetsuro Kubota, Koichiro Kumai, Masaki Kitajima.   

Abstract

We report herein the case of 64-year-old man with gastrointestinal stromal tumor (GIST), who was treated by partial resection of the duodenum after preoperative transarterial embolization. He presented to our hospital with a history of tarry stools, dizziness, and severe anemia (hemoglobin, 7.5 g/dl). Gastroduodenal endoscopy revealed the presence of a submucosal tumor in the second portion of the duodenum. The presence of the tumor was subsequently confirmed by double-contrast gastrointestinal radiography and abdominal computed tomography. Super-selective angiography showed tumor staining fed from the anterior and posterior superior pancreaticoduodenal arteries, and the inferior pancreaticoduodenal artery. Two weeks after transarterial embolization through these vessels, the tumor size was found to have shrunk to 40% of its original size. Partial resection of the duodenum was performed and absence of tumor cells at the surgical margin was confirmed by intraoperative frozen-section examination. Histopathological examination revealed that the duodenal submucosal tumor consisted of spindle cells, and immunohistochemical analysis revealed positive tumor staining for c-kit protein, CD34 and alpha-smooth muscle actin (SMA), and negative staining for desmin and S-100; the positivity rate for MIB-1 staining was 2.2%. Based on these findings, the tumor was diagnosed as a GIST of low-grade malignancy, classified as the muscular type. It is considered that preoperative treatment of duodenal GISTs, such as transarterial embolization, may be useful for reducing the extent of resection, from pancreaticoduodenenctomy to a partial resection.

Entities:  

Mesh:

Year:  2005        PMID: 16369749     DOI: 10.1007/s10147-005-0503-z

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.850


  15 in total

1.  Laparoscopic wedge resection of gastric submucosal tumors.

Authors:  Y Otani; M Ohgami; N Igarashi; M Kimata; T Kubota; K Kumai; M Kitajima; M Mukai
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2000-02       Impact factor: 1.719

Review 2.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

3.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

Authors:  S Hirota; K Isozaki; Y Moriyama; K Hashimoto; T Nishida; S Ishiguro; K Kawano; M Hanada; A Kurata; M Takeda; G Muhammad Tunio; Y Matsuzawa; Y Kanakura; Y Shinomura; Y Kitamura
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

4.  CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.

Authors:  M Sarlomo-Rikala; A J Kovatich; A Barusevicius; M Miettinen
Journal:  Mod Pathol       Date:  1998-08       Impact factor: 7.842

Review 5.  Gastrointestinal stromal tumors: biology and treatment.

Authors:  Florence Duffaud; Jean-Yves Blay
Journal:  Oncology       Date:  2003       Impact factor: 2.935

6.  Prognostic factors in primary gastrointestinal leiomyosarcoma: a retrospective study.

Authors:  H Kimura; Y Yonemura; N Kadoya; T Kosaka; K Miwa; I Miyazaki; T Sawa; S Yoshimitsu; Y Nishida; T Kamata
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

7.  Segmental resection of the third portion of the duodenum for a gastrointestinal stromal tumor: a case report.

Authors:  Yoshihiro Sakamoto; Junji Yamamoto; Hidenori Takahashi; Norihiro Kokudo; Toshiharu Yamaguchi; Tetsuichiro Muto; Masatoshi Makuuchi
Journal:  Jpn J Clin Oncol       Date:  2003-07       Impact factor: 3.019

8.  Gastric stromal tumors. Reappraisal of histogenesis.

Authors:  M T Mazur; H B Clark
Journal:  Am J Surg Pathol       Date:  1983-09       Impact factor: 6.394

9.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Charles D Blanke; Annick D Van den Abbeele; Burton Eisenberg; Peter J Roberts; Michael C Heinrich; David A Tuveson; Samuel Singer; Milos Janicek; Jonathan A Fletcher; Stuart G Silverman; Sandra L Silberman; Renaud Capdeville; Beate Kiese; Bin Peng; Sasa Dimitrijevic; Brian J Druker; Christopher Corless; Christopher D M Fletcher; Heikki Joensuu
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

10.  Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

Authors:  Michael C Heinrich; Christopher L Corless; George D Demetri; Charles D Blanke; Margaret von Mehren; Heikki Joensuu; Laura S McGreevey; Chang-Jie Chen; Annick D Van den Abbeele; Brian J Druker; Beate Kiese; Burton Eisenberg; Peter J Roberts; Samuel Singer; Christopher D M Fletcher; Sandra Silberman; Sasa Dimitrijevic; Jonathan A Fletcher
Journal:  J Clin Oncol       Date:  2003-12-01       Impact factor: 44.544

View more
  11 in total

1.  Segmental duodenectomy for gastrointestinal stromal tumor of the duodenum.

Authors:  Nicolas Christian Buchs; Pascal Bucher; Pascal Gervaz; Sandrine Ostermann; François Pugin; Philippe Morel
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

2.  Role of interventional radiology in the emergent management of acute upper gastrointestinal bleeding.

Authors:  Rakesh Navuluri; Jay Patel; Lisa Kang
Journal:  Semin Intervent Radiol       Date:  2012-09       Impact factor: 1.513

3.  Acute lower gastrointestinal bleeding.

Authors:  Rakesh Navuluri; Lisa Kang; Jay Patel; Thuong Van Ha
Journal:  Semin Intervent Radiol       Date:  2012-09       Impact factor: 1.513

4.  Embolization of nonliver visceral tumors.

Authors:  Paul G Thacker; Jeremy L Friese; Matthew Loe; Peter Biegler; Michael Larson; James Andrews
Journal:  Semin Intervent Radiol       Date:  2009-09       Impact factor: 1.513

5.  Dramatic regression and bleeding of a duodenal GIST during preoperative imatinib therapy: case report and review.

Authors:  Andreas Hecker; Birgit Hecker; Birgit Bassaly; Markus Hirschburger; Thilo Schwandner; Hermann Janssen; Windried Padberg
Journal:  World J Surg Oncol       Date:  2010-06-02       Impact factor: 2.754

6.  Feasibility and oncological outcomes of limited duodenal resection in patients with primary nonmetastatic duodenal GIST.

Authors:  Ahmed El-Gendi; Saba El-Gendi; Mohamed El-Gendi
Journal:  J Gastrointest Surg       Date:  2012-09-25       Impact factor: 3.452

7.  Simple segmental resection of the second portion of the duodenum for the treatment of gastrointestinal stromal tumors.

Authors:  Masami Asakawa; Yoshihiro Sakamoto; Takahiro Kajiwara; Satoshi Nara; Minoru Esaki; Kazuaki Shimada; Tetsuya Hamaguchi; Tomoo Kosuge
Journal:  Langenbecks Arch Surg       Date:  2007-11-17       Impact factor: 3.445

8.  Gastrointestinal stromal tumour of the duodenum in childhood: a rare case report.

Authors:  Massimo Chiarugi; Christian Galatioto; Piero Lippolis; Giuseppe Zocco; Massimo Seccia
Journal:  BMC Cancer       Date:  2007-05-09       Impact factor: 4.430

9.  Surgical treatment of gastrointestinal stromal tumors of the duodenum: a literature review.

Authors:  Georgi Popivanov; Mihail Tabakov; George Mantese; Roberto Cirocchi; Irene Piccinini; Vito D'Andrea; Piero Covarelli; Carlo Boselli; Francesco Barberini; Renata Tabola; Ursi Pietro; Davide Cavaliere
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-21

10.  Segmental resection of the duodenum for gastrointestinal stromal tumor (GIST).

Authors:  Rudolf Mennigen; Heiner H Wolters; Bernd Schulte; Friedrich W Pelster
Journal:  World J Surg Oncol       Date:  2008-09-30       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.